Norcam Pharma Private Limited - Company Profile

It is a chemicals private limited company based in New Delhi, Delhi, India, established in 2012.
2012 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Norcam Pharma Private Limited

Norcam Pharma Private Limited, a struck off private limited company, was established on 18 October 2012 in New Delhi, Delhi, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24297DL2012PTC243851. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Pushpa Surender Sharma (Director), Alok Kumar (Director), Anil Kumar (Director). Its latest AGM occurred on 28 August 2013, with the balance sheet filed on 31 March 2013. It is based at Flat No. 671, Air Force Naval Officers Enclave, Plot No.11, Sector-7, Dwarka, New Delhi, Delhi, 110075.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24297DL2012PTC243851

  • Registration Number

    243851

  • Incorporation Date

    18 October 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 6 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Norcam Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Norcam Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Norcam Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Pushpa Surender Sharma Director 18 Oct 2012 Current
Alok Kumar Director 18 Oct 2012 Current
Anil Kumar Director 18 Oct 2012 Current
Surender Kumar Sharma Director 18 Oct 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Norcam Pharma.

Enhance accessibility to Norcam Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Norcam Pharma revenue growth over time
Norcam Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Norcam Pharma?

Unlock access to Norcam Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Norcam Pharma?

Unlock and access historical data on people associated with Norcam Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Norcam Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Norcam Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Norcam Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Norcam Pharma Private Limited last Annual general meeting of members was held on 28 Aug 2013 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Norcam Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Delhi. was completed.

  • Director Appointment

    Progress on Pushpa Surender Sharma was appointed as a Director was appointed as a Director on 18 Oct 2012 & has been associated with this company since 13 years 6 months . was documented.

  • Director Appointment

    The activity Alok Kumar was appointed as a Director was appointed as a Director on 18 Oct 2012 & has been associated with this company since 13 years 6 months . was completed.

  • Director Appointment

    Anil Kumar was appointed as a Director was appointed as a Director on 18 Oct 2012 & has been associated with this company since 13 years 6 months . was recorded as a recent event.

  • Director Appointment

    Surender Kumar Sharma was appointed as a Director was appointed as a Director on 18 Oct 2012 & has been associated with this company since 13 years 6 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Norcam Pharma Private Limited?

The CIN of Norcam Pharma Private Limited is U24297DL2012PTC243851.

Where is Norcam Pharma Private Limited headquartered?

Norcam Pharma Private Limited is headquartered at Flat No. 671, Air Force Naval Officers Enclave, Plot No.11, Sector-7, Dwarka, New Delhi, Delhi, 110075.

When was Norcam Pharma Private Limited incorporated?

Norcam Pharma Private Limited was incorporated on 18 October 2012.

Who are the current directors of Norcam Pharma Private Limited?

The current directors of Norcam Pharma Private Limited are

What is the primary industry of Norcam Pharma Private Limited?

The primary industry of Norcam Pharma Private Limited is Chemicals.

Is Norcam Pharma Private Limited a listed company?

Norcam Pharma Private Limited is unlisted.

What is the capital structure of Norcam Pharma Private Limited?

The authorized capital of Norcam Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available